Galapagos NV GLPG-NL:Euronext Amsterdam

*Data is delayed | EUR
Last | 03/04/21 CET
71.38UNCH (UNCH)
52 week range
64.52 - 216.10

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close71.38
  • 52 Week High216.10
  • 52 Week High Date05/12/20
  • 52 Week Low64.52
  • 52 Week Low Date02/16/21
  • Market Cap5,412.12M
  • Shares Out65.41M
  • 10 Day Average Volume473,457
  • Dividend-
  • Dividend Yield-
  • Beta0.52
  • 1 Year % Change-63.8

RATIOS/PROFITABILITY

  • EPS (TTM)-4.78
  • P/E (TTM)-14.92
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

QUOTE FINDER

Profile

MORE
Galapagos NV is a Belgium-based clinical-stage biotechnology company. The Company is focused on the discovery and development of small molecule medicines with novel modes of action. Its pipeline comprises Phase 3, 2, 1, pre-clinical studies and discovery small-molecule and antibody programs in cystic fibrosis, inflammation, and other indications. The Company aims to develop a portfolio of clinical-stage therapies for the enhancement of existing treatment paradigms. In...
Raj Parekh
Non-Executive Chairman
Bart Filius
Chief Financial Officer
Address
Generaal De Wittelaan 3
Malines (mechelen)
2800
Belgium